InvestorsHub Logo

sirant

04/16/14 10:59 AM

#180076 RE: 4u2nv2 #180075

GOOD solid news. I am glad I am a shareholder in this company.

GO MCIC

gorbec1

05/16/14 9:28 AM

#181180 RE: 4u2nv2 #180075

Dr. Greg Maguire, CEO of BioRegenerative Sciences, Inc, stated, "Our group is very excited to help bring this important new drug candidate for migraines through the FDA 505(b)(2) NDA approval process. Dr Valentin Isacescu added, "Migraine is such a debilitating disorder for so many patients and a tremendous need exists for a medication to prevent and control this malady."